Carboxypeptidase B2 Peptide
€100.00
In stock
SKU
350565
Protein Family: Peptidases, Enzymes.
Pathway and Disease: Immune System, Signaling Molecules and Interaction
Alternate Names: CPB2; CPU; pCPB; PASP; Pancreas-specific protein; Carboxypeptidase B2; Carboxypeptidase U; TAFI; Thrombin-activable fibrinolysis inhibitor; Plasma carboxypeptidase B
Accession No.: Q96IY4, NP_001863
Description:
Carboxypeptidase B2 preferentially releases the C-terminal amino acids Arg and Lys from biologically active peptides such as Kinins and Anaphylatoxins thus rendering them inactive.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2030.2 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200203 is selected from a sequence within the Central region of Carboxypeptidase B2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C86H132N24O31S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Immune System, Signaling Molecules and Interaction
Alternate Names: CPB2; CPU; pCPB; PASP; Pancreas-specific protein; Carboxypeptidase B2; Carboxypeptidase U; TAFI; Thrombin-activable fibrinolysis inhibitor; Plasma carboxypeptidase B
Accession No.: Q96IY4, NP_001863
Description:
Carboxypeptidase B2 preferentially releases the C-terminal amino acids Arg and Lys from biologically active peptides such as Kinins and Anaphylatoxins thus rendering them inactive.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2030.2 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200203 is selected from a sequence within the Central region of Carboxypeptidase B2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C86H132N24O31S1
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review